Product Name:Potassium thiocyanate

IUPAC Name:

CAS:333-20-0
Molecular Formula:CKNS
Purity:98%
Catalog Number:CM000375
Molecular Weight:97.18

Packing Unit Available Stock Price($) Quantity
CM000375-500g 1-2 Weeks ſȌ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:333-20-0
Molecular Formula:CKNS
Melting Point:-
Smiles Code:[S-]C#N.[K+]
Density:
Catalog Number:CM000375
Molecular Weight:97.18
Boiling Point:
MDL No:MFCD00011413
Storage:

Column Infos

Crinecerfont
The New England Journal of Medicine publishes the primary CAHtalyst™ Adult Phase 3 study results of Crinecerfont for the treatment of congenital adrenal hyperplasia (CAH). Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a rare genetic disorder, affected by a lack of cortisol and/or aldosterone. Corticotropin-releasing factor type 1 receptor (CRF1) antagonism is shown to clinically decrease ACTH production and adrenal androgen levels.
Neurocrine's Crinecerfont is an investigational, selective CRF1 antagonist being developed to reduce and control excess adrenocorticotropic hormone (ACTH) and adrenal androgens. The phase 3 study meets primary and important key secondary endpoints, including a significant reduction in androstenedione levels and lowering glucocorticoid dosing.